Tramadol and Oxycodone Side Effects Comparison

Introduction to Side Effects

Tramadol generally produces more neurological side effects, including seizure risk and serotonin syndrome, while oxycodone causes more classic opioid-related adverse effects such as respiratory depression and higher addiction potential, according to the American Society of Clinical Oncology 1

Tramadol has a higher risk of seizures, especially at doses exceeding 400mg daily, as reported by the National Comprehensive Cancer Network 2, 3
Tramadol causes dizziness, weakness, and confusion more commonly than other opioids, as noted by the National Comprehensive Cancer Network 2, 4
Tramadol has a risk of serotonin syndrome when combined with SSRIs, TCAs, or MAOIs, according to the National Comprehensive Cancer Network 3, 4
Tramadol has limitations in dose titration related to low threshold for neurotoxicity, as reported by the American Society of Clinical Oncology 1

Tramadol produces nausea and vomiting more frequently than hydrocodone and codeine in cancer patients, as reported by the National Comprehensive Cancer Network 2, 5
Oxycodone has a higher incidence of constipation due to stronger opioid effects, according to the National Comprehensive Cancer Network 3
Comparative studies suggest tapentadol (similar to tramadol) has a lower incidence of GI adverse effects than oxycodone, as noted by the National Comprehensive Cancer Network 3

Lower doses of tramadol are recommended for older adults (≥75 years), as reported by the National Comprehensive Cancer Network 2, 3
Dose reduction is needed in hepatic and renal dysfunction to reduce seizure risk, according to the National Comprehensive Cancer Network 3, 4
The maximum recommended dose of tramadol is 400mg daily for immediate-release and 300mg daily for extended-release, as noted by the National Comprehensive Cancer Network 3, 4

For severe pain requiring strong analgesia, oxycodone is more effective but carries a higher risk of classic opioid side effects, as reported by the American Society of Clinical Oncology 1
In patients taking serotonergic medications, oxycodone is safer than tramadol, according to the American Society of Clinical Oncology and the National Comprehensive Cancer Network 1, 4

The World Journal of Emergency Surgery recommends considering tramadol for patients with oxycodone intolerance due to its weaker mu-opioid receptor activity and reduced gastrointestinal effects, but only if the intolerance involves classic opioid side effects 6

The World Journal of Emergency Surgery warns that tramadol is contraindicated in patients with a history of seizures, as it lowers the seizure threshold 6
The World Journal of Emergency Surgery also recommends dose reduction in elderly patients (≥75 years) due to increased confusion risk 6

The Annals of Oncology notes that tramadol may cause more nausea and vomiting than hydrocodone and codeine in comparative trials, with a strength of evidence based on multiple guidelines 7
The American Heart Association reclassified tramadol as a Schedule IV controlled opioid in 2014, and it should be reconsidered for routine use in cardiovascular disease given abuse potential, as reported in Circulation 8

The Annals of Oncology and ESMO guidelines recommend considering low doses of strong opioids (like morphine) as an alternative to weak opioids such as tramadol, due to the ceiling effect and unpredictable efficacy of tramadol 7, 9, 10
The Annals of Oncology notes that morphine efficacy is independent of CYP2D6 polymorphism, providing more predictable analgesia, although this specific fact is not directly cited, the overall recommendation is based on 9